HEALTHCARE ROYALTY PARTNERS
We are a $3.0+ billion global healthcare investment firm. We invest primarily in commercial stage healthcare product assets that have significant clinical value, strong barriers to entry and that are marketed by some of the world’s largest pharmaceutical companies. Over the past decade, our senior investment team has completed more than 60 royalty investments valued in excess of $2.5 billion. For more information, visit www.healthcareroyalty.com.
HEALTHCARE ROYALTY PARTNERS
Industry:
Asset Management Biotechnology Financial Services Medical Device Pharmaceutical
Founded:
2007-01-01
Status:
Active
Contact:
203.487.8300
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Domain Not Resolving Wordpress Plugins
Current Advisors List
Advisor
2009-01-01
Board_member
2009-01-01
Current Employees Featured
Clarke B. Futch Chairman & Chief Executive Officer @ HealthCare Royalty Partners
Chairman & Chief Executive Officer
Conrad Wang Principal @ HealthCare Royalty Partners
Principal
2015-10-01
Paul J Hadden Senior Managing Director @ HealthCare Royalty Partners
Senior Managing Director
Timothy Bryant General Counsel @ HealthCare Royalty Partners
General Counsel
Gregory B. Brown, MD Founding Managing Director @ HealthCare Royalty Partners
Founding Managing Director
2007-01-01
Todd C. Davis Founding Managing Director @ HealthCare Royalty Partners
Founding Managing Director
Christopher White Chief Operating Officer @ HealthCare Royalty Partners
Chief Operating Officer
2014-12-01
Thomas K. Conner CFO @ HealthCare Royalty Partners
CFO
2011-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-08 | Clearside Biomedical | HealthCare Royalty Partners investment in Post-IPO Debt - Clearside Biomedical | 65 M USD |
| 2022-06-30 | Ardelyx | HealthCare Royalty Partners investment in Post-IPO Debt - Ardelyx | 20 M USD |
| 2022-06-16 | Rhythm Pharmaceuticals | HealthCare Royalty Partners investment in Post-IPO Debt - Rhythm Pharmaceuticals | 37.5 M USD |
| 2021-09-30 | Spero Therapeutics | HealthCare Royalty Partners investment in Post-IPO Debt - Spero Therapeutics | 125 M USD |
| 2019-03-04 | Portola Pharmaceuticals | HealthCare Royalty Partners investment in Post-IPO Debt - Portola Pharmaceuticals | 125 M USD |
| 2019-01-08 | Coherus Biosciences | HealthCare Royalty Partners investment in Post-IPO Debt - Coherus Biosciences | 75 M USD |
| 2016-04-14 | TearScience | HealthCare Royalty Partners investment in Series D - TearScience | 19.23 M USD |
| 2015-02-13 | Invuity | HealthCare Royalty Partners investment in Private Equity Round - Invuity | 22.9 M USD |
| 2014-11-13 | Helomics | HealthCare Royalty Partners investment in Series E - Helomics | 60 M USD |
| 2014-09-18 | Cardiorentis | HealthCare Royalty Partners investment in Series A - Cardiorentis | 45 M EUR |
More informations about "HealthCare Royalty Partners"
HealthCare Royalty Partners - Crunchbase
HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors. New. Resources. Advanced Search. ... 776 Number of Organizations • $84.1B Total Funding …See details»
HealthCare Royalty Partners - Org Chart, Teams, Culture & Jobs
HealthCare Royalty Partners (“HCR”) is a private investment firm that purchases royalties and uses debt-like structures to invest in commercial or near-commercial stage biopharmaceutical …See details»
HealthCare Royalty Partners Information - RocketReach
HealthCare Royalty Partners ("HCR") is a leading royalty acquisition company focused on commercial or near-commercial stage biopharmaceutical products. HCR has raised over $6.2 …See details»
Royalty Monetization | HealthCare Royalty Partners
HealthCare Royalty Partners - Overview, News & Similar
Jan 2, 2024 HealthCare Royalty Announces Closing of Credit Facility, New Debt Focused Fund and Appointment of Josh House as West Coast Lead STAMFORD, Conn.--(BUSINESS …See details»
Team | HealthCare Royalty Partners
HealthCare Royalty Partners team is comprised of former pharmaceutical executives, physicians, bankers, equity analysts, lawyers and consultants. ... our Senior Advisor Board consists of …See details»
HealthCare Royalty Partners - VC Firm Profile - gaebler.com
Jul 31, 2015 HealthCare Royalty Partners is a global healthcare investment firm. Launched in 2007 by Founding Managing Directors Gregory B. Brown, M.D., Todd C. Davis and Clarke B. …See details»
HealthCare Royalty Partners - Investor in Stamford, Connecticut
Healthcare is what we know. Healthcare is where we invest. We are former surgeons, pharmaceutical executives, bankers, equity analysts, lawyers, and consultants. We have …See details»
Healthcare Royalty Partners - Company Database - Wall Street Oasis
Healthcare Royalty Partners Overview Healthcare Royalty Partners Job Openings View All Roles No jobs found. $10m+ Est Annual Revenue. $5bn-$8bn. AUM. Industry. Private Equity. …See details»
HealthCare Royalty Partners - Investments, Portfolio & Company …
HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors. New. Resources. Advanced Search. ... Which industries …See details»
HealthCare Royalty Partners investment portfolio - PitchBook
HealthCare Royalty Partners's latest investment was on 06-Feb-2023 in AstraZeneca (Global Rights to Movantik), a company within the Buildings and Property industry. Data …See details»
HealthCare Royalty Company Profile - Office Locations ... - Craft
HealthCare Royalty has 5 employees across 4 locations. See insights on HealthCare Royalty including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Healthcare Royalty Partners | Institution Profile | Private Equity ...
Established in 2007, Healthcare Royalty Partners is a Stamford-headquartered firm with offices in Boston, San Francisco and London. The firm targets equity and debt investments in …See details»
HOME - WoodBridge Healthcare
WoodBridge Healthcare is a not-for-profit, 501(c)(3) organization dedicated to helping hospitals and health systems provide high-quality, patient-centered care and community support. Our …See details»
Improving Health Outcomes Through Innovative Partnerships
Apr 19, 2024 Raleigh, NC & Woodbridge, VA –Racial and minority individuals face disproportionately high rates of health issues, including diabetes, hypertension, maternal and …See details»
The Waterloo Regional Health Network Board of Directors is …
April 01, 2025 – The Waterloo Regional Health Network Board of Directors is proud to announce the appointment of Ron Gagnon as the inaugural President & CEO of the newly merged …See details»
HealthCare Royalty Partners - Funding, Financials, Valuation
HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors. New. Resources. Advanced Search. ... Browse By: …See details»
One patient, one chart: The Royal among six hospitals joining Epic ...
Apr 3, 2025 By fall 2026, patients and healthcare providers at any of the 16 partner organizations will have access to the health records they need with just a few clicks. This …See details»
Sentara Northern Virginia Medical Center names new president
Joyner is returning to the Washington metropolitan area having held healthcare leadership positions that include: Vice President, Professional Services at Sibley Memorial Hospital in …See details»
HealthCare Royalty Partners - Contacts, Employees, Board …
HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors.See details»